VIDA Diagnostics Announces Expanded Board of Directors
Board of Directors Strengthens VIDA for Next Phase of Growth
CORALVILLE, Iowa, Dec. 2, 2014 /PRNewswire/ -- VIDA Diagnostics, Inc. ("VIDA") announced the expansion of its board of directors appointing three new members. Craig Ibsen, Michael Minette, and Philip Smith, join VIDA's board to add critical industry and financial expertise to help guide VIDA's next phase of strategic growth.
"As VIDA advances its leading pulmonary imaging informatics solution into routine clinical care, it is of great benefit to have the advice of industry and financial leaders with unique understanding of the role of advanced imaging analytics in healthcare," says Susan A. Wood, Ph.D., President and CEO of VIDA. "I am grateful for the support and advice of Craig, Mike and Phil as VIDA continues its growth trajectory."
About Craig Ibsen
Craig has over 25 years of investment, entrepreneurial and senior management experience in the US and globally. He is a founder of Next Level Ventures, a new $30M late stage venture capital firm located in Des Moines, investing in growing companies that are based in Iowa. Craig currently serves as Director of Industry People Group, Fitness on Request and was the former Chairman of Global ID Group which was acquired by Inverness Graham in 2013. He holds an MBA from Drake University and a BA from Luther College.
About Michael Minette
Mike is a Vice President of Corporate Development & Strategy, supporting and leading global growth and acquisition initiatives for Exact Sciences, and formally for Covidien's Early Technologies division. With over sixteen years in healthcare and transactions, Mike provides diverse operational experiences that include: sales, marketing, project management, product development, general management, and strategy consulting. He has executed over 40 M&A / transactions in his career. Prior to Exact Sciences and Covidien, Mike led and managed business development and M&A transactions across General Electric Healthcare's portfolio of businesses. Mike holds a Bachelor of Arts in Finance from the University of Northern Iowa, Master of Business Administration in Strategy, Finance & Management from Loyola University of Chicago, and graduate of University of Chicago's Mergers & Acquisition program.
About Philip Smith
Phil has amassed extensive healthcare transaction expertise during his career as both an investment banker and an executive officer of emerging medtech companies. Prior to joining Greene Holcomb Fisher, he spent 11 years in various executive roles in strategy and business development, and as CEO. In these capacities and as a consumer of investment banking services, Phil obtained significant acquisition and strategic partnering experience from the operating client perspective. He has also served on boards both as an independent director and as CEO. Previously, Phil was a healthcare investment banker at Piper Jaffray, where he was heavily involved in M&A and public equity transactions with industry-leading medical technology and health services organizations. Phil holds an MBA from the Wharton School of Business and an BS in electrical engineering from the University of Florida.
About VIDA
VIDA is a leading imaging informatics company for the early detection, diagnosis and therapeutic planning of pulmonary disease. In the emerging era of cost containment and outcomes-based patient management strategies, VIDA extends the value of medical imaging to the objective, accurate and repeatable standard demanded by pulmonary clinicians for critical decision support. VIDA offers a unique lung imaging evaluation service, quantitative-imaging-as-a service, that is a combination of software automation, quality assurance and consultative expertise. The cutting edge methodology provides doctors with objective metrics for diagnostic tests, patient therapeutic appropriateness and guidance. VIDA's technologic solution uses an evidence-based approach and machine learning, which models the disease characteristics and prior patient response. VIDA is FDA approved, ISO13485, CE (European Economic Area), TGA (Australia) and CMDCAS (Canada) certified. VIDA's offices are located in Palo Alto, CA, and Coralville, IA.
For more, visit www.vidadiagnostics.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vida-diagnostics-announces-expanded-board-of-directors-300003780.html
SOURCE VIDA Diagnostics, Inc.
Share this article